Patents/Assignees

Shanghai Cell Therapy Group Co., Ltd.

3 patents in portfolio

US12618066utility2026
Promoter Having High Activity in Activated T-cell
0 cites
US12358994utility2025
Antibody-modified Chimeric Antigen Receptor Modified T Cell and Uses Thereof
0 cites
US12042515utility2024
Killer Cell Capable of Efficiently and Stably Expressing Antibody, and Uses Thereof
0 cites